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Abstract
Background: Control of brucellosis in livestock, wildlife and humans depends on the reliability of
the methods used for detection and identification of bacteria. In the present study, we describe the
evaluation of the recently established real-time PCR assay based on the Brucella-specific insertion
sequence IS711 with blood samples from 199 wild boars (first group of animals) and tissue samples
from 53 wild boars (second group of animals) collected in Switzerland. Results from IS711 real-time
PCR were compared to those obtained by bacterial isolation, Rose Bengal Test (RBT), competitive
ELISA (c-ELISA) and indirect ELISA (i-ELISA).
Results: In the first group of animals, IS711 real-time PCR detected infection in 11.1% (16/144) of
wild boars that were serologically negative. Serological tests showed different sensitivities [RBT
15.6%, c-ELISA 7.5% and i-ELISA 5.5%] and only 2% of blood samples were positive with all three
tests, which makes interpretation of the serological results very difficult. Regarding the second
group of animals, the IS711 real-time PCR detected infection in 26% of animals, while Brucella spp.
could be isolated from tissues of only 9.4% of the animals.
Conclusion: The results presented here indicate that IS711 real-time PCR assay is a specific and
sensitive tool for detection of Brucella spp. infections in wild boars. For this reason, we propose the
employment of IS711 real-time PCR as a complementary tool in brucellosis screening programs
and for confirmation of diagnosis in doubtful cases.
Background
Brucellosis is a widespread zoonosis of great economic
importance caused by facultative intracellular Gram-neg-
ative bacteria belonging to the genus Brucella. Although
brucellosis in domestic animals has been eradicated in
great number of European countries, the risk of reintro-
duction of the disease still exists through spill-over from
wildlife that are considered to be natural reservoirs [1]. A
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study on the surveillance of different swine pathogens
demonstrated the presence of Brucella suis biovar 2 in a
population of wild boars in Switzerland [2,3].
Reliable and sensitive diagnostic tools play a crucial role
in the control of brucellosis in livestock, wildlife and
humans. Although blood and tissue cultures remain the
'gold standard' for diagnosis, they show low sensitivity,
are time consuming, and represent a risk for laboratory
personnel [4,5].
Serology is a standard method for the epidemiological
surveillance of brucellosis [2,3,6-9]. However, cross-reac-
tions between Brucella species and other Gram-negative
bacteria, such as Yersinia enterocolitica O:9, Francisella tula-
rensis, Escherichia coli O:157, Salmonella urbana group N,
Vibrio cholerae and  Stenotrophomonas maltophilia, are a
major problem of the serological assays [10-13]. The
source of antigenic cross-reactions is the O-chain of the
smooth lipopolysaccharide (S-LPS) present on the surface
of the bacterial cell, which shows great similarity in
smooth Brucella spp. and the abovementioned bacteria
[14]. False-positive serological results due only to Y. ente-
rocolitica O:9 affect up to 15% of the cattle herds in regions
free from brucellosis, generating considerable additional
costs for surveillance programs [13]. False-negative results
have also been observed in serological diagnosis of bru-
cellosis [11,15-17]. They occur mostly due to the fact that
the antibody response is dependent upon the stage of
infection during sample collection [18]. For example,
Leal-Klevezas and colleagues stated that detectable
amounts of antibodies are not recorded in the first 12–16
days after artificial inoculation of goats with Brucella abor-
tus [19]. On the other hand, when the disease becomes
chronic, the antibody titre could fall to undetectable levels
[17,20], which is especially the case with intracellular
organisms like Brucella spp. [21]. Latent infection without
seroconversion further complicates the problem, particu-
larly in pre-pubertal animals [22].
Molecular diagnostic techniques represent an important
breakthrough in the diagnostic practice. A number of
genus- or species-specific conventional PCR assays using
primers derived from different gene sequences from the
Brucella  genome, such as 16S rRNA [23], the 16S-23S
intergenic spacer region [24], omp2 [25] and bcsp31 [26],
have been established. These assays were adapted for
application to Brucella detection in different clinical spec-
imens. In the majority of studies, conventional PCR
proved to be a good means to detect Brucella DNA from
clinical specimens [27-35], while Romero and colleagues
found that PCR had lower sensitivity compared to the
conventional detection methods [36].
The introduction of real-time PCR offers improved sensi-
tivity, specificity and speed of performance compared
with conventional PCR. Several real-time PCR assays
using different detection chemistries have already been
established for Brucella identification [37-39]. Moreover,
some of them were evaluated with various clinical sam-
ples of human and animal origins [40-45]. Most of the
authors confirmed that real-time PCR was a very sensitive
method of detection from clinical samples [41,43,44];
nevertheless, O'Leary and colleagues found that there was
no advantage in using real-time PCR on blood, milk and
lymph node samples of naturally infected cows over
standard serological and bacteriological methods [45].
The goal of our present study was to evaluate the perform-
ance of a recently described real-time PCR assay [46] for
Brucella spp. detection with wild boar blood and tissue
samples collected under the wild boar surveillance pro-
gram in Switzerland. This assay is based on the Brucella
spp. specific multiple IS711 insertion sequence and there-
fore shows great sensitivity [46]. The same samples were
additionally tested by bacterial isolation and three sero-
logical tests (i-ELISA, c-ELISA and RBT), and the results
obtained were compared to those of the real-time PCR.
Results
Bacteriological isolation
There were no differences in the results obtained with bac-
teriological isolation before and after freezing of the tissue
samples. Brucella was isolated from tissue samples of 5
(9.4%) out of 53 animals (Table 1). According to the bac-
terial isolation method, the highest prevalence was found
in tissues of reproductive organs (three isolates in uterus,
one in accessory sexual glands, one in preputium). Bru-
cella was also isolated from one spleen and one lung sam-
ple. All Brucella strains were identified as B. suis biovar 2.
Table 2 shows the detection of Brucella spp. in individual
tissue samples by bacterial isolation and IS711 real-time
PCR. In three animals, bacterial colonies with morpholog-
ical characteristics similar to Brucella spp. were isolated.
Their lysates tested negative with the IS711 real-time PCR
assay and were subsequently submitted for 16S rRNA gene
sequence analysis. The sequence showed 99% identity
with Bisgaard Taxon 10 (Pasteurellaceae).
No Brucella bacteria could be isolated from blood sam-
ples.
Table 1: Detection of Brucella spp. in tissue samples by bacterial 
isolation and IS711 real-time PCR from wild boars.
Positive samples
Method Number of animals No. %
Bacterial isolation 53 5 9.4
IS711 real-time PCR 53 14 26BMC Veterinary Research 2009, 5:22 http://www.biomedcentral.com/1746-6148/5/22
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Serological testing
Sera from 199 animals were tested with 3 different sero-
logical methods. RBT showed the highest sensitivity,
detecting 31 (15.6%) positive samples while results could
not be obtained for 4 (2%) samples due to strong haemo-
lysis. With the c-ELISA, 15 (7.5%) samples tested positive.
i-ELISA detected 11 (5.5%) positive samples, while 6
(3%) samples showed equivocal results. Table 3 summa-
rises the results of the different methods used for testing
the blood samples. Only 4 (2%) samples were found pos-
itive with all 3 serological tests. Figure 1 and Table 4 show
the comparative analysis of positive samples detected
with both serology and IS711 real-time PCR.
Testing of tissue samples with IS711 real-time PCR
The signal for 18S rRNA gene (endogenous extraction
control) was detected for all samples. By testing tissue
samples originating from 53 wild boars, all 5 positive
(9.4%) animals detected by bacterial isolation were also
detected by IS711 real-time PCR. Furthermore, with the
IS711 real-time PCR, we were able to additionally detect
nine (17%) infected animals that were negative by the
bacterial isolation method. Interestingly, in 10 out of 14
positive animals, IS711 real-time PCR was able to detect
Brucella-specific DNA in every organ that was available for
examination. Table 1 shows the number of positive ani-
mals detected by bacterial isolation and IS711 real-time
PCR. Table 2 shows the detection of Brucella spp. in indi-
vidual tissue samples by bacterial isolation and IS711 real-
time PCR. The quantification of bacteria per host cell in
various organs revealed that of the 14 real-time PCR posi-
tive animals, 11 of them had the largest quantities of Bru-
cella DNA in sexual organs (uterus, uterine fluid, testicle
or accessory sexual gland), ranging up to 8081 IS711 cop-
ies pro 1000 cells. In two animals the spleen was princi-
pally affected (7 and 74.5 IS711 copies pro 1000 cells),
Table 2: Detection of Brucella spp. in tissue samples by bacterial isolation and IS711 real-time PCR.
Tissue samples
Spleen Acc. sex glands Testicles Uterus Other
Positive 
Animal
Bact. 
Isolation
IS711 RT-
PCR
Bact. 
isolation
IS711 RT-
PCR
Bact. 
isolation
IS711 RT-
PCR
Bact. 
isolation
IS711 RT-
PCR
Bact. 
isolation
IS711 RT-
PCR
1++ ++
2-+++-+ + a +a
3-+ ++
4-+-+-+
5-+ -+ + b +b
6-- -+
7-- -+
8-+ -+
9-+ -c +c
1 0 -+-+-+
1 1 ---+--
1 2 -+-+-+ - d +d
13 - + + +
1 4 -+-+-+
a Preputium
b Lungs
c Placenta
d Urine
Table 3: Results of different methods for Brucella spp. diagnosis from blood samples in wild boars.
Positive samples detected Equivocal samples No resulta
Method Total Samples No. % No. % No. %
i-ELISA 199 11 5.5 6 3
c-ELISA 199 15 7.5
RBT 199 31 15.6 4 2
IS711 real-time PCR 199 27 13.6 9 4.5
a The results could not be obtained for four samples tested with RBT due to strong haemolysis, and for nine samples tested with IS711 real-time 
PCR because of inhibition caused by their poor qualityBMC Veterinary Research 2009, 5:22 http://www.biomedcentral.com/1746-6148/5/22
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whereas in only one animal the largest Brucella  DNA
quantity was found in urine (2.5 IS711 copies pro 1000
cells).
Testing of blood samples with IS711 real-time PCR
As already mentioned, only leukocyte pellets were used
for DNA extraction from blood samples. In 9 out of 199
(4.5%) samples, results were not obtained with the real-
time PCR due to inhibition caused by the poor quality of
the given blood samples. The signal for 18S rRNA gene
(endogenous extraction control) was detected for all sam-
ples, except the nine aforementioned samples that were
inhibited. Out of 199 blood samples, 27 (13.6%) tested
positive with the IS711 real-time PCR. Surprisingly, IS711
real-time PCR detected infection in 11.1% (16/144) of
wild boars that were serologically negative. Table 3 sum-
marises the results of the different methods used for test-
ing blood samples.
Discussion
In this study, we report the performance of the recently
described real-time PCR assay for the detection of Brucella
spp. [46] in blood and tissue samples from naturally
infected wild boars. Results obtained were compared with
the results of bacterial isolation and three different sero-
logical tests for detection of brucellosis: RBT, i-ELISA and
c-ELISA. This real-time PCR assay is very appealing as a
diagnostic tool because it targets the IS711 insertion ele-
ment, which is present in multiple copies in Brucella
genomes and at the same time represents a stable genetic
element with respect to number and positions in the
genomes of various Brucella species [47,48]. The IS711
real-time PCR assay has been shown to be specific for Bru-
cella spp. with a detection limit of 10 copies, indicating
high assay sensitivity [46].
Regarding Brucella spp. detection in wild boar tissue sam-
ples, the IS711 assay was able to additionally detect Bru-
cella DNA in tissues of 9 (17%) animals that were negative
by bacterial isolation (Table 1 and 2). This low sensitivity
of the culture method has already been reported by differ-
ent authors [4,5]. The significantly higher detection sensi-
tivity of real-time PCR can be explained by the fact that it
detects DNA from bacteria that are damaged and nonvia-
ble and therefore impossible to isolate by conventional
cultures. In 10 out of 14 real-time PCR positive animals,
the IS711 real-time PCR assay was able to detect Brucella
DNA from almost every organ that was submitted for
examination (Table 2). The quantification of bacteria per
host cell in various organs revealed that in 11 of the real-
time PCR positive animals, the largest quantities of Bru-
cella DNA were found in sexual organs, in two animals the
spleen was principally affected, whereas in only one ani-
mal the largest Brucella DNA quantity was found in urine.
These differences probably correlated with the stage of
infection in individual animals. Since the samples at our
disposition originated from animals shot by hunters, it
was impossible to compare the variation in sensitivity of
the different methods during the course of infection,
according to clinical status or age.
No Brucella bacteria could be isolated from blood sam-
ples. This is in concordance with the reports of other
authors stating that recovery of the bacteria by blood and
milk culture is insensitive [19].
In contrast, IS711 real-time PCR was able to detect Bru-
cella DNA in 27 (13.6%) out of 199 blood samples (Table
3). It is relevant to mention that the PCR performance
with the Brucella DNA extracted from blood samples is
very often compromised by the presence of PCR inhibi-
tors and further complicated because Brucella is an intrac-
ellular pathogen [27]. However, the protocols presented
here make detection of Brucella DNA from blood samples
more feasible because only the leukocyte pellet was used
for DNA extraction. Although it was reported that high
concentrations of leukocyte DNA could inhibit the PCR
assay [49], the IPC (internal positive control) signal was
Venn diagram showing a summary of serological (RBT, c- ELISA and i-ELISA) and IS711 real-time PCR results for blood  samples from wild boars Figure 1
Venn diagram showing a summary of serological 
(RBT, c-ELISA and i-ELISA) and IS711 real-time PCR 
results for blood samples from wild boars. Footnote: In 
order to simplify the comparison, the six equivocal samples 
in i-ELISA, four blood samples for which the result was not 
obtained with RBT, and nine samples inhibited in the real-
time PCR were not included in the comparison (total 
number of blood samples included into the comparison anal-
ysis n = 180).
IS711
PCR
RBT i-ELISA
c-ELISA
16 2
19
44
2
2
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detected for all samples used in this assay except for nine
samples, which were inhibited due to poor blood sample
quality.
It is interesting to remark the discrepancies with the sero-
logical results. Comparing serology with the results of the
IS711 assay, only 2 (1.1%) out of 180 samples included in
the comparative analysis were positive with all serological
tests and IS711  real-time PCR (Figure 1 and Table 4).
Interestingly, IS711 real-time PCR detected infection in
11.1% (16/144) of the seronegative wild boars (Figure 1
and Table 4), which prompts us to conclude that these
were probably acute or chronically infected animals with
antibody levels beyond the detectable limit. Latent infec-
tion without seroconversion further complicates the prob-
lem, particularly in pre-pubertal animals [22]. While PCR
directly detects the DNA of the pathogen, the serology is
dependent upon the variable titres of antibodies in differ-
ent phases of the disease [18]. On the other hand, 18%
(28/156) of IS711 real-time PCR negative samples were
seropositive in our study, which could be either due to a
lack of sensitivity of the real-time PCR technique or sero-
logical false positives. Keeping in mind the well docu-
mented problem of extensive serological cross-reactions
with other bacteria [10,12,13,22], it is highly likely that a
great number of these samples were indeed false positives.
Further difficulties associated with serological testing in
wildlife is the fact that most tests have been directly trans-
posed, without validation, from their use in domestic ani-
mals to the wild species, even though they may not
perform identically [22].
In summary, in this study, the IS711 real-time PCR was
able to increase the number of positive animals which
were negative by bacterial isolation and detect additional
positive animals that were seronegative. Moreover, not all
the seropositive animals were detected positive by the
IS711  real-time PCR. Therefore, it is important to use
more than one type of diagnostic techniques for the detec-
tion of brucellosis in animals, which is an issue that has
already been addressed by different authors [50,51].
Conclusion
The IS711 assay described here is a sensitive and specific
method for detection of Brucella spp. in blood and tissue
specimens of wild boars. Since the data on prevalence of
brucellosis in wild boar populations is still being esti-
mated by serology [2,3,6-9], we are of the opinion that
this assay should be included in brucellosis screening pro-
grams in order to complement the drawbacks of the con-
ventional detection methods. Additionally, this assay
should also be a method of choice for diagnosis of brucel-
losis in various wild and zoo animals, considering that
current serological tests are evaluated only for domestic
animals.
Methods
Study design and collection of clinical specimens
The clinical material to be tested in this study originated
from a population of wild boars in Switzerland that, as
demonstrated by Leuenberger and colleagues, represents a
natural reservoir of Brucella suis biovar 2 [2]. The tissue
and blood samples collected do not originate from the
same animals and were collected under the national sur-
veillance program for infectious diseases for wild boars,
organized by the Swiss Federal Veterinary Office. The first
group of samples consisted of various organs originating
from 53 animals: spleen, testicles (tissue samples from
both testicles of each boar were examined separately),
accessory sexual glands, uteri in different stages of gravid-
ity as well as non-gravid uteri samples, lung, and in indi-
vidual cases penis with prepuce, placenta, kidney, and
bladder containing urine. The organs were collected dur-
ing the hunting seasons of 2001/2002 and 2002/2003
and stored at -20°C. Bacterial isolation from the organs
was immediately done after the samples arrived to our
laboratory. However, and in order to compare bacterial
isolation results with these of the real-time PCR, bacterial
isolation experiments were repeated and done simultane-
ously with the real-time PCR three to five years later. The
second group of clinical samples consisted of 199 blood
samples (in some animals a sero-sanguineous fluid from
the thoracic cavity was taken), each from one animal. The
sera were separated and examined by serological tests
Table 4: Brucella spp. positive samples detected with IS711 real-time PCR and serological tests.
Positive samples detected
Method No. %
IS711 real-time PCR (only) 16 8.9
IS711 real-time PCR and one serological test 6 3.3
IS711 real-time PCR and two serological tests - -
IS711 real-time PCR and three serological tests 2 1.1
In order to simplify the comparison, the six equivocal samples in i-ELISA, four blood samples for which the result was not obtained with RBT, and 
nine samples inhibited in the real-time PCR were not included in the comparison (total number of blood samples included into the comparison 
analysis n = 180).BMC Veterinary Research 2009, 5:22 http://www.biomedcentral.com/1746-6148/5/22
Page 6 of 8
(page number not for citation purposes)
while the remaining blood clots were frozen at -20°C for
one to two years and used for bacterial cultivation and
DNA extraction for IS711 real-time PCR analysis.
Bacteriological isolation
Tissue samples were thawed, the surfaces were heat steri-
lised and an internal sub-sample was inoculated onto
three different nutritive media: Tryptic Soy Agar (TSA)
plates containing 5% sheep blood (Oxoid, Basingstoke,
Hampshire, England), Brolac agar (BioMérieux, Genève,
Switzerland), and Brucella agar. Brucella agar was made
from Brucella medium base (Oxoid) containing 5% inac-
tivated horse serum with Modified Brucella Selective Sup-
plement (Oxoid, SR0209E), as described in the OIE
Manual of Standards for Diagnostic Tests and Vaccines,
2008 [52]. Brolac agar was used in order to facilitate the
identification of contaminants growing on the blood
plate, which, as expected, were very abundant because the
samples were partially autolytic. The cultures were incu-
bated at 37°C under an atmosphere with 5% CO2.
Growth and morphology of the colonies were monitored
on the second and fifth days after inoculation. For cultiva-
tion of blood samples, the leukocyte pellet obtained from
300 μl of blood clots (semi-liquid consistency) was inoc-
ulated on the plates. Only blood samples that tested pos-
itive with the IS711 real-time PCR were used for bacterial
cultivation. Suspicious colonies were identified as Brucella
spp. based on morphological, cultural and biochemical
characteristics, such as oxidase and urease tests. The final
species and biovar differentiations were done at the
French OIE Reference Laboratory (Agence Française de
Sécurité Sanitaire des Aliments, Cedex).
Serological testing
Sera were tested for antibodies against Brucella using com-
petitive ELISA (SVANOVIR® Brucella-Ab c-ELISA, Svanova
Biotech AG Uppsala, Sweden), indirect ELISA (CHEKIT®
Brucella suis, Dr. Bommeli AG/Idexx, Switzerland) and
Rose Bengal spot agglutination test (RBT) as recom-
mended by the OIE Manual of Standards for Diagnostic
Tests and Vaccines, 2008 [52]. The cut-off values for the c-
ELISA and i-ELISA were determined according to the man-
ufacturers' guidelines. Although routinely performed at
our institute, complement fixation test (CFT) is not ade-
quate as a confirmatory test for haemolytic sera of wild
boars from the hunting bag and therefore could not be
used for these samples.
DNA extraction from clinical samples
DNA from 25 to 30 mg of tissue (or 10 mg of spleen) and
100 μl of liquid samples, such as amniotic fluid and urine,
were extracted using the QIAamp® DNA Mini Kit (QIA-
GEN, Basel, Switzerland) according to the manufacturer's
tissue protocol. For the DNA extraction from blood sam-
ples, only the leukocyte pellet was used. Briefly, 300 μl of
blood clots (semi-fluid consistency) was resuspended in
600  μl erythrocyte lysis buffer (1.55 M NH4Cl, 0.1 M
KHCO3, 1 mM Titriplex III, 10× conc.) and 300 μl PBS
buffer. The suspension was mixed, incubated for 10 min-
utes and centrifuged at 8000 rpm for 2 minutes. The
supernatant was discarded and the treatment with eryth-
rocyte lysis solution was repeated until the leukocyte pel-
lets lost all reddish colouring. The DNA from the
leukocyte pellet was extracted following the tissue proto-
col of the QIAamp® DNA Mini Kit (QIAGEN). The Taq-
Man®  Ribosomal RNA Control Reagent (Applied
Biosystems, Foster City, CA, USA) designed to detect the
18S ribosomal RNA (rRNA) gene highly conserved among
a diverse group of eukaryotes was used as an endogenous
control of DNA extraction.
IS711 real-time PCR
The primers and TaqMan®  probe selected from the
sequences of the IS711 element and used for amplifica-
tion and detection were described previously by Hiniæ
and colleagues [46]. Briefly, real-time amplifications were
performed using 2.5 μl of DNA extract, 300 nM of each
primer, 200 nM probe and TaqMan® Universal PCR Mas-
ter Mix, No AmpErase® UNG (Applied Biosystems) in a
25-μl volume. An exogenous Internal Positive Control
(IPC, Applied Biosystems) was added to each reaction,
according to the manufacturer's protocol, in order to
check for the presence of PCR inhibitors. Amplification
and real-time fluorescence detection was performed on a
TaqMan® 7500 Real-time PCR system (Applied Biosys-
tems) according to the standard protocol. A positive result
was indicated by fluorescence above a threshold of 0.06
with the auto settings used for the baseline.
Quantification of bacteria
The TaqMan® Ribosomal RNA Control Reagent (Applied
Biosystems) designed to detect the 18S ribosomal RNA
(rRNA) gene was used as an endogenous extraction con-
trol and for quantification of host cells. The quantification
of bacteria per host cell in various organs was done using
the standard curve method (User's Manual, ABI PRISM
7700 Sequence Detection System, Applied Biosystems).
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